Dow Jones

39 150,33

0,04%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Hubei Minkang Pharmaceutical Ltd (GM) (HBMK)
Hubei Minkang Pharmaceutical Ltd (GM) (HBMK) Actualités

HBMK

Hubei Minkang Pharmaceut... (GM) (HBMK)

Hubei Minkang Pharmaceutical Ltd (GM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:HBMK

Date	Heure	Source	Titre	Symbole	Société
31/03/2015	14h55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
14/08/2014	22h29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
16/05/2014	19h39	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
15/04/2014	22h51	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
31/03/2014	23h18	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
18/09/2013	23h01	OTC Markets	Venue Change	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
01/08/2013	20h19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
10/06/2013	22h45	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
01/04/2013	18h51	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
01/04/2013	18h51	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
27/03/2013	20h22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
27/03/2013	20h04	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
19/11/2012	19h15	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
14/11/2012	20h25	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
11/09/2012	22h53	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
15/05/2012	23h01	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
15/05/2012	22h05	Marketwired	Hubei Minkang Pharmaceutical Ltd. Closes Private Placement of $791,189	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
03/05/2012	21h25	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
16/04/2012	23h27	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
30/03/2012	12h06	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
28/03/2012	22h15	Marketwired	Hubei Minkang Pharmaceutical Ltd. Signs a MOU With Hubei Merryclin Pharmaceuticals	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
29/02/2012	20h18	Marketwired	Hubei Minkang Pharmaceutical Co., Ltd. Signs an MOU with Henan Wanlong Pharmaceutical	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
22/12/2011	12h02	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
06/10/2011	20h32	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
06/10/2011	20h11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/A)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
05/10/2011	18h46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
22/09/2011	15h00	Marketwired	Hubei Minkang Pharmaceutical Ltd. Completes Acquisition of 100% of HBMK Pharmaceutical Limited	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
12/07/2011	12h02	Edgar (US Regulatory)	Statement regarding change in majority of directors pursuant to Rule 14f-1 (SC 14F1)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
11/07/2011	19h03	Marketwired	Hubei Minkang Pharmaceutical Ltd. Enters Into Share Exchange Agreement to Acquire 100% of HBMK Pharmaceutical Limited	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
21/10/2010	18h59	Marketwired	Hubei Minkang Pharmaceutical Ltd.: Letter of Intent Signed to Acquire 100% of HBMK Limited	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)